Clinical trial Recruiting at 2 sites Interventional Ages 18 to 35

Exploring how social reward learning affects social pleasure in first-episode psychosis

Official title: Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis Using Motivational Interviewing in a Perturbation-Based Neuroimaging Approach

Run by University of Alabama at Birmingham · NCT05617898 · Data updated 2026-11-12

This study is testing whether different types of support can help young adults who have just experienced their first episode of psychosis feel more pleasure from social interactions.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment152 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations2 sites (Birmingham, Alabama and 1 other locations)
StatusRecruiting
StartedJune 14, 2023
Main results expectedNovember 2027
Study endsNovember 2027
Registry record updatedJuly 27, 2026
Trial IDNCT05617898 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-35 who have experienced their first episode of psychosis within the last three years and are currently on second-generation antipsychotic medications.

Probably not a fit

Patients with substance-induced psychosis or significant substance use disorders in the past three months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the connection between reduced sensitivity to social rewards and social anhedonia in individuals who have recently experienced their first episode of psychosis. Participants aged 18-35 will be randomized to receive either motivational interviewing or a control intervention, with their responses measured through social reward learning tasks performed in an fMRI scanner. The study aims to assess both behavioral and neural correlates of social reward sensitivity and subjective social pleasure. By understanding these relationships, the trial seeks to inform potential therapeutic approaches for enhancing social functioning in this population.

Why it matters

Potential benefit: If successful, this study could lead to improved interventions for enhancing social engagement and pleasure in individuals with psychosis.

How similar studies have gone: While the specific approach of this study may be novel, similar studies have shown promise in understanding the role of social rewards in mental health conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-35 years
* A first episode of a psychotic illness that began within the past three years
* Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of schizophrenia, schizophreniform, or schizoaffective disorder
* Taking 2nd generation antipsychotic medications
* Estimated premorbid IQ not less than 70 as assessed with the Wechsler Test of Adult Reading
* Appropriate for scanning (i.e., no pacemaker or metal implants) and expressed willingness to participate in scanning
* Sufficient fluency in English to comprehend testing procedures
* Corrected vision of at least 20/30

Exclusion Criteria:

* No evidence that substance use makes the diagnosis ambiguous (rule out substance-induced psychosis)
* No evidence of moderate or severe alcohol or substance use disorder in the past 3 months
* No clinically significant disease based on medical history (e.g., epilepsy) or significant head injury
* For females: no current pregnancy
* No sedatives or anxiolytics on the day of assessment
* No medication change 3 weeks prior to enrollment

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • University of California Los Angeles
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.